Meeting
2019 ASCO Annual Meeting
Is immunotherapy toxicity associated with improved overall survival among older adults with advanced cancer?
Authors
Andrew Johns
Dept. of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
Andrew Johns , Madison Grogan , Rebecca Hoyd , John F.P Bridges , Lai Wei , Sandipkumar Patel , Mingjia Li , Marium Husain , Kari Lynn Kendra , Gregory Alan Otterson , Jarred Thomas Burkart , Ashley Elizabeth Rosko , Barbara L. Andersen , David Paul Carbone , Dwight Hall Owen , Daniel Spakowicz , Carolyn J Presley
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Outcomes
Citation
J Clin Oncol 37, 2019 (suppl; abstr 6580)
DOI
10.1200/JCO.2019.37.15_suppl.6580
Abstract #
6580
Poster Bd #
271
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Impact of comorbidity burden on immune-related adverse events and survival among older adults with cancer on immunotherapy.
First Author: Andrew T. Faucheux
Poster
2023 ASCO Annual Meeting
Frailty IO: Frailty parameters and incidence of immune related adverse events in older patients treated with immune checkpoint blockers (ICB).
First Author: Capucine Baldini
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Efficacy and tolerability of immune checkpoint inhibitors in elderly patients with MSI/dMMR gastrointestinal cancers and impact of toxicities on efficacy: The immunoMSI cohort.
First Author: Leah Mailly-Giacchetti
Poster
2022 ASCO Annual Meeting
Association between immune-related adverse events and microbiome composition in patients with advanced non–small cell lung cancer treated with immunotherapy.
First Author: Marion Tonneau